Monitoring fasting insulin, glucose, and CGM data is important for detecting insulin resistance in patients taking statins before hemoglobin A1c crosses the type 2 diabetes threshold.

“we want to know the minute you're becoming insulin resistant in response to the Statin and those data are less clear you don't know exactly how many people are getting insulin and resistant but this is a reason to be paying attention to bigger markers and more important markers than just hemoglobin A1c trips over the threshold of 6.5% you have type 2 diabetes here you want to be able to say is the hemoglobin A1c moving what's happening to the fasting insulin and glucose and these other markers does a patient wear a CGM one of the reasons we like cgms on patients when we put them on statins is we we have a historical level of what their glucose control looks like and if all of a sudden their Baseline average glucose goes up by 10 milligrams per Des Sol which I've seen in patients on a Statin I know it's you know that's not just a quick dietary trigger especially when you take them off the Statin and it comes right back down to normal”